Allurion Technologies (ALUR) Income from Continuing Operations (2022 - 2026)
Allurion Technologies (ALUR) posted Income from Continuing Operations of 6095000.0 for Q1 2026, up 2.96% on a QoQ basis from 6281000.0 in Q4 2025, and down 306.06% year-over-year from 2957838.67 in Q1 2025.
Allurion Technologies (ALUR) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Allurion Technologies' Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 6095000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 306.06% year-over-year to 6095000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33595000.0 (down 206.61% YoY) and the FY2025 annual result came in at 28954000.0, down 291.59% from the prior year.
- Income from Continuing Operations was 6095000.0 for Q1 2026 at Allurion Technologies, up from 6281000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8705000.0 in Q3 2024 and bottomed at 21996000.0 in Q2 2023.
- A 5-year average of 9836750.0 and a median of 9569500.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 306.96% — and 2024, when it jumped 140.25%.
- Allurion Technologies' Income from Continuing Operations stood at 13014000.0 in 2022, then sank by 64.36% to 21390000.0 in 2023, then jumped by 54.17% to 9804000.0 in 2024, then jumped by 35.93% to 6281000.0 in 2025, then climbed by 2.96% to 6095000.0 in 2026.
- Business Quant data shows ALUR's Income from Continuing Operations at 6095000.0 in Q1 2026, 6281000.0 in Q4 2025, and 11884000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -9.80 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | -13.01 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |